CVS® is alleged to have broken the barrier between its SilverScript® prescription drug plan, CVS® Caremark—its pharmacy middleman—and its vast chain of retail stores in a scheme intended to block seniors’ access to cheaper generic drugs in exchange for big rebates from the manufacturers of covered brand names.

For example, the fraudulent scheme is believed to disproportionately affected elderly patients with end-stage renal failure, while forcing many beneficiaries of the SilverScript® Part D program to go without critical treatment because they were unable to access generic versions of necessary drugs at affordable costs. But privately insured patients were also allegedly impacted by the CVS-Drugmaker pricing scheme. 

Some prescription medicines involved in the fraudulent pricing scheme include: 

• Advair Diskus—Asthma and chronic obstructive pulmonary disease
• Asacol HD—Inflammatory bowel disease, including ulcerative colitis and Crohn's disease
• Canasa Rectal Suppository—Active ulcerative proctitis (ulcerative rectal colitis)
• Copaxone—Multiple sclerosis
• Epclusa—Treatment of hepatitis C
• Exelon—Alzheimer’s Disease
• Harvoni—Treatment of hepatitis C
• Invega—Schizophrenia
• Istalol—Ocular hypertension and glaucoma
• Renvela Packets—Chronic kidney disease on dialysis
• Renvela Tablets—Chronic kidney disease on dialysis
• Ventolin HFA—Bronchospasm
• Voltaren Gel—Arthritis Pain
• Xopenex HFA—Asthma and chronic obstructive pulmonary disease

Consumers who became victims of the alleged scheme—those forced to split doses, skip doses, or stop taking vital medications altogether—are encouraged to submit a case evaluation form for injuries, some of which may include:

• Withdrawal symptoms that required medical care;
• New illness or injury caused by under-treatment of primary disease;
• Loss or reduction of mobility;
• Worsening or prolonging the medical condition for which the drug was prescribed;
• Suicide or inpatient treatment for suicidal ideation; and,
• Death.

We provide experienced, trusted representation starting with a free, private case evaluation—to discuss a potential case of pharmaceutical fraud with an experienced attorney, click the button below to find out how.